CoChat

Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults

Open access
Derry, Sheena, Wiffen, Philip J, Moore, R Andrew, McNicol, Ewan D, Bell, Rae F, Carr, Daniel B, McIntyre, Mairead, Wee, Bee · 2017 · Cochrane Database of Systematic Reviews
Cited by 82

The DOI matches its Crossref record.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy of oral NSAIDs for cancer pain in adults, and the adverse events associated with their use in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd012638

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 67

  1. AlBalawi, 2013, Random error in cardiovascular meta-analyses: how common are false positive and false negative results?, Interational Journal of Cardiology, 168, 1102, 10.1016/j.ijcard.2012.11.048 · DOI
  2. Azevedo São Leão Ferreira, 2006, The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?, Support Care Cancer, 14, 1086, 10.1007/s00520-006-0086-x · DOI · Paper page
  3. Bao, 2016, Hydromorphone for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011108.pub2 · DOI
  4. Breivik, 2009, Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes, Annals of Oncology, 20, 1420, 10.1093/annonc/mdp001 · DOI · Paper page
  5. Brok, 2009, Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses, International Journal of Epidemiology, 38, 287, 10.1093/ije/dyn188 · DOI · Paper page
  6. Brune, 2004, The discovery and development of anti-inflammatory drugs, Arthritis and Rheumatology, 50, 2391, 10.1002/art.20424 · DOI
  7. Brune, 2015, New insights into the use of currently available nonsteroidal anti-inflammatory drugs, Journal of Pain Research, 8, 105, 10.2147/JPR.S75160 · DOI · Paper page
  8. Carlson, 2016, Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review, Journal of Pain Research, 9, 515, 10.2147/JPR.S97759 · DOI · Paper page
  9. Chell, 2005, Prospects in NSAID-derived chemoprevention of colorectal cancer, Biochemical Society Transactions, 33, 667, 10.1042/BST0330667 · DOI
  10. 2014, Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet, 382, 769
  11. Deandrea, 2008, Prevalence of undertreatment in cancer pain. A review of published literature, Annals of Oncology, 19, 1985, 10.1093/annonc/mdn419 · DOI · Paper page
  12. Dechartres, 2013, Influence of trial sample size on treatment effect estimates: meta-epidemiological study, BMJ, 346, f2304, 10.1136/bmj.f2304 · DOI · Paper page
  13. Dechartres, 2014, Association between analytic strategy and estimates of treatment outcomes in meta-analyses, JAMA, 312, 623, 10.1001/jama.2014.8166 · DOI · Paper page
  14. Deng, 2012, The relationship between cancer pain and quality of life in patients newly admitted to Wuhan Hospice Center of China, American Journal of Hospital Palliative Care, 29, 53, 10.1177/1049909111418636 · DOI
  15. Derry, 2014, Caffeine as an analgesic adjuvant for acute pain in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009281.pub3 · DOI · Paper page
  16. Dreidi, 2016, Pain, sleep disturbance, and quality of life among Palestinian patients diagnosed with cancer, Journal of Cancer Education, 31, 796, 10.1007/s13187-015-0946-5 · DOI
  17. Dwivedi, 2015, Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs), Drug Discovery Today, 20, 863, 10.1016/j.drudis.2015.03.004 · DOI
  18. Dworkin, 2008, Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations, Journal of Pain, 9, 105, 10.1016/j.jpain.2007.09.005 · DOI · Paper page
  19. Elbourne, 2002, Meta-analyses involving cross-over trials: methodological issues, International Journal of Epidemiology, 31, 140, 10.1093/ije/31.1.140 · DOI · Paper page
  20. Effective Practice Organisation of Care (EPOC) 23. Worksheets for preparing a Summary of Findings using GRADE. Resources for review authors epoc.cochrane.org/epoc-specific-resources-review-authors
  21. Fanelli, 2017, Meta-assessment of bias in science, Proceedings of the National Academy of Sciences of the United States of America, epub
  22. Gavaghan, 2000, An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data, Pain, 85, 415, 10.1016/S0304-3959(99)00302-4 · DOI · Paper page
  23. Guyatt, 2011, GRADE guidelines: 7. Rating the quality of evidence - inconsistency, Journal of Cinical Epidemiology, 64, 1294, 10.1016/j.jclinepi.2011.03.017 · DOI · Paper page
  24. Guyatt, 2013, GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, Journal of Clinical Epidemiology, 66, 151, 10.1016/j.jclinepi.2012.01.006 · DOI · Paper page
  25. Guyatt, 2013, GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes, Journal of Clinical Epidemiology, 66, 158, 10.1016/j.jclinepi.2012.01.012 · DOI · Paper page
  26. Hadley, 2013, Transdermal fentanyl for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010270.pub2 · DOI
  27. Hinz, 2007, Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic, Federation of American Societies for Experimental Biology Journal, 21, 2343, 10.1096/fj.06-8061com · DOI
  28. Hinz, 2008, Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man, Federation of American Societies for Experimental Biology Journal, 22, 383, 10.1096/fj.07-8506com · DOI · Paper page
  29. Häuser, 2012, The German fibromyalgia consumer reports - a cross-sectional survey, BMC Musculoskeletal Disorders, 13, 74, 10.1186/1471-2474-13-74 · DOI · Paper page
  30. IntHout, 2015, Small studies are more heterogeneous than large ones: a meta-meta-analysis, Journal of Clinical Epidemiology, 68, 860, 10.1016/j.jclinepi.2015.03.017 · DOI · Paper page
  31. Jadad, 1995, The WHO analgesic ladder for cancer pain management. Stepping up the quality of Its evaluation, JAMA, 274, 1870, 10.1001/jama.1995.03530230056031 · DOI · Paper page
  32. Laine, 2001, Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient, Gastroenterology, 120, 594, 10.1053/gast.2001.21907 · DOI · Paper page
  33. Mangoni, 2010, Use of nonsteroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community, British Journal of Clinical Pharmacology, 69, 689, 10.1111/j.1365-2125.2010.03627.x · DOI
  34. McQuay, 1998, An Evidence-based Resource for Pain Relief
  35. McQuay, 2005, Placebo, Postgraduate Medical Journal, 81, 155, 10.1136/pgmj.2004.024737 · DOI · Paper page
  36. McQuay, 2014, Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies, British Journal of Cinical Pharmacology, 63, 271, 10.1111/j.1365-2125.2006.02723.x · DOI · Paper page
  37. Mercadante, 2013, The long and winding road of nonsteroidal anti-inflammatory drugs and paracetamol in cancer pain management: a critical review, Critical Reviews in Oncology/Hematology, 87, 140, 10.1016/j.critrevonc.2013.01.001 · DOI
  38. Mikan, 2016, The association between pain and quality of life for patients with cancer in an outpatient clinic, an inpatient oncology ward, and inpatient palliative care units, American Journal of Hospital Palliative Care, 33, 782, 10.1177/1049909116630266 · DOI
  39. Moore, 1998, Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects, Pain, 78, 209, 10.1016/S0304-3959(98)00140-7 · DOI · Paper page
  40. Moore, 2008, Managing potential publication bias, 15
  41. Moore, 2010, Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice, Annals of the Rheumatic Diseases, 69, 374, 10.1136/ard.2009.107805 · DOI · Paper page
  42. Moore, 2013, Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome, Anaesthesia, 68, 400, 10.1111/anae.12148 · DOI · Paper page
  43. Moore, 2014, The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain, Pain Practice, 14, 79, 10.1111/papr.12050 · DOI · Paper page
  44. Moore, 2013, What works for whom? Determining the efficacy and harm of treatments for pain, Pain, 154 Suppl 1, S77, 10.1016/j.pain.2013.03.024 · DOI · Paper page
  45. Moore, 2014, Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk, Pain Practice, 14, 378, 10.1111/papr.12100 · DOI
  46. Nabal, 2012, The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. a systematic review of the literature, Palliative Medicine, 26, 305, 10.1177/0269216311428528 · doi:10.1177/0269216311428528
  47. Nguyen, 2017, Simple randomization did not protect against bias in smaller trials, Journal of Clinical Epidemiology, epub
  48. Nüesch, 2010, Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study, BMJ, 341, c3515, 10.1136/bmj.c3515 · DOI · Paper page
  49. Portenoy, 1999, Management of cancer pain, Lancet, 353, 1695, 10.1016/S0140-6736(99)01310-0 · DOI · Paper page
  50. Prommer, 2015, Pharmacological management of cancer-related pain, Cancer Control, 22, 412, 10.1177/107327481502200407 · DOI
  51. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
  52. Roberts, 2015, The knowledge system underpinning healthcare is not fit for purpose and must change, BMJ, 350, h2463, 10.1136/bmj.h2463 · DOI · Paper page
  53. Schmidt-Hansen, 2015, Buprenorphine for treating cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009596.pub4 · DOI
  54. Schmidt-Hansen, 2015, Oxycodone for cancer-related pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003870.pub5 · DOI
  55. Sheen, 2002, Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen., Pharmacoepidemiology and Drug Safety, 11, 329, 10.1002/pds.701 · DOI · Paper page
  56. Straube, 2014, Codeine, alone and with paracetamol (acetaminophen), for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006601.pub4 · DOI
  57. Thorlund, 2011, The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study, PLOS One, 6, e25491, 10.1371/journal.pone.0025491 · DOI · Paper page
  58. Turner, 2013, The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews, PLOS One, 8, e59202, 10.1371/journal.pone.0059202 · DOI · Paper page
  59. Twycross, 2014, Palliative Care Formulary
  60. Beuken-van Everdingen, 2016, Update on prevalence of pain in patients with cancer: systematic review and meta-analysis, Journal of Pain and Symptom Management, 51, 1070, 10.1016/j.jpainsymman.2015.12.340 · DOI · Paper page
  61. Wender, 2015, Aspirin and NSAID chemoprevention, gene-environment interactions, and risk of colorectal cancer, JAMA, 313, 1111, 10.1001/jama.2015.1032 · DOI
  62. Wiffen, 2014, Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011056 · DOI
  63. Wiffen, 2015, Oral tapentadol for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011460 · DOI
  64. Wiffen, 2016, Oral morphine for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003868.pub4 · DOI
  65. Wiffen, 2017, Tramadol with or without paracetamol (acetaminophen) for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012508 · DOI
  66. Wolfe, 2014, Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia, European Journal of Pain, 17, 581, 10.1002/j.1532-2149.2012.00234.x · DOI · Paper page
  67. McNicol, 2015, NSAIDS or paracetamol, alone or combined with opioids, for cancer pain, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005180.pub2 · DOI

Cited by

See all 82

Metadata

Authors
Derry, S., Wiffen, P. J., Moore, R. A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B.
Venue
Cochrane Database of Systematic Reviews
Published
2017-04-25
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4235711782
Cited by
82
References
0
Type
reference entry
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. https://app.cochat.ai/papers/10.1002/14651858.cd012638
The paper
Derry, S., Wiffen, P. J., Moore, R. A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017). Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd012638

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.